相关实验视频

Updated: Sep 15, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

无法治愈的负担:儿童干细胞移植后的铁过载

Yonatan Diamond¹, Alexandra Satty¹, Lenat Joffe¹

¹Northwell, New Hyde Park, NY, USA; Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.

Blood cells, molecules & diseases

|July 17, 2025

概括

铁过载 (IOL) 对血造干细胞移植 (HSCT) 的儿科和年轻成年幸存者来说是一个日益关注的问题. 这次审查涉及IOL.

科学领域:

血液学血液学血液学
移植医学移植医学
儿科瘤学儿科瘤学

背景情况:

铁过载 (IOL) 是儿科和年轻成年人造血干细胞移植 (HSCT) 幸存者的重大并发症.
它有助于大量的发病率和死亡率由于多因素的原因,包括输血负担和铁代谢受损.
有限的共识指导方针存在,用于管理这种脆弱人群中的IOL.

研究的目的:

在HSCT的背景下,审查铁代谢的生理学和病理生理学.
检查儿科和年轻成人HSCT幸存者的内腔眼镜的临床影响和挑战.
在这个人口群体中讨论基于证据的预防和治疗IOL的策略.

主要方法:

文献综述侧重于铁代谢,HSCT后的IOL病原体和临床管理策略.
对目前关于内腔眼镜诊断,监测和治疗的证据的分析.
强调儿童,青少年和年轻人面临的具体挑战.

主要成果:

IOL后HSCT的结果来自复杂的相互作用,包括输血需求,红色素质问题和改变的铁吸收.
毒性非转林结合铁的积累导致氧化应激和组织损伤.
个性化管理和警监测对于最佳结果至关重要.

结论:

在HSCT后的铁过载带来了独特的挑战,需要针对儿科和年轻成年幸存者的量身定制方法.
为了有效的诊断,监测和管理,需要进一步的研究和共识指南.
预防和治疗的积极战略对于缓解长期并发症至关重要.

关键词:

造血干细胞移植造血干细胞移植铁化铁化铁铁过载是因为铁过载.弗莱博托米 (Phlebotomy) 是一种手术.

更多相关视频

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...